Geyer Mark A, Ellenbroek Bart
Department of Psychiatry, University of California at San Diego, 9500 Gilman Drive, 0804, La Jolla, CA 92093-0804, USA.
Prog Neuropsychopharmacol Biol Psychiatry. 2003 Oct;27(7):1071-9. doi: 10.1016/j.pnpbp.2003.09.003.
This review describes the animal behavior models that provide insight into the mechanisms underlying the critical differences between the actions of typical vs. atypical antipsychotic drugs. Although many of these models are capable of differentiating between antipsychotic and other psychotropic drugs, only a few seem to be able to differentiate between typical and atypical antipsychotics, such as the paw test and the phencyclidine (PCP)-induced disruption of prepulse inhibition (PPI) of startle in rats. Moreover, there is an urgent need for animal models focusing more on the negative and the cognitive symptoms. Hence, improved animal models are crucial for developing better treatments for schizophrenia.
本综述描述了一些动物行为模型,这些模型有助于深入了解典型与非典型抗精神病药物作用之间关键差异的潜在机制。尽管其中许多模型能够区分抗精神病药物和其他精神药物,但似乎只有少数模型能够区分典型和非典型抗精神病药物,如大鼠的爪部试验和苯环己哌啶(PCP)诱导的惊吓前脉冲抑制(PPI)破坏试验。此外,迫切需要更多关注阴性和认知症状的动物模型。因此,改进动物模型对于开发更好的精神分裂症治疗方法至关重要。